Page 15 - சிகிச்சையகம் ஆரோக்கியம் அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mayo Clinic Infectious Disease expert weighs in on the effectiveness of Pfizer vaccine for kids Pfizer said its study showed 100-percent effectiveness in 12 to 15-year-olds April 1, 2021 4:27 PM Martha Koloski Updated: LA CROSSE, Wis. (WKBT) – Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12-years-old, which is a big step toward possibly beginning shots in that age group before they head back to school in the fall. Pfizer said its study showed 100% effectiveness in 12 to 15-year-olds and they reported high levels of virus-fighting anti-bodies, even higher than in young adults. Infectious Disease Specialist at Mayo Clinic Health System Dr. Abinash Virk said, “I think that is great news! I think that is particularly great news for the 12 to 16-year-olds who have co-morbidities that put them at increased risk for severe Covid, so that’s excellent news.”

Martha koloskiAbinash virkClinic health system drMayo clinic infectious diseaseDisease specialistClinic health systemஅபிநஸ் கன்னிசிகிச்சையகம் ஆரோக்கியம் அமைப்பு டாக்டர்மயோ சிகிச்சையகம் தொற்று நோய்நோய் நிபுணர்சிகிச்சையகம் ஆரோக்கியம் அமைப்பு